Only 5 small low quality studies were included in this review of botulinum toxin (BoNT-A ) injections for sleep bruxism. 3 of the included studies were RCTs and while a potential benefit from use of BoNT-A treatment was suggested the findings should be treated very cautiously.

Six small RCTs were included in this review. Findings suggest that botulinum toxin type A (BoTN-A) has a positive effect on post treatment pain. Hover the results should be interpreted cautiously as the quality of the evidence is limited and more high quality studies are needed.

The review of sleep bruxism was only able to identify 12 small low quality RCTs covering a range of treatments. Most evidence was available for oral appliances but there is no sufficient evidence to state that the occlusal splint is effective for treating sleep bruxism.

This review of botulinum toxin (BTX) for treating temporomandibular disorders identified 5 RCTs involving a total of 117 patients. There was marked heterogeneity between the studies and the therapeutic benefits are unclear. Well reported high quality RCTs are needed.

Bruxism can be classified as primary (idiopatic) or secondary (iatrogenic). While secondary bruxism is associated with medical conditions (e.g. neurologic, psychiatric, sleep disorders medication), primary bruxism ( which includes clenching and sleep bruxism ) is not. Dental treatments for bruxism include occlusion adjustment, tooth surface restoration, and orthodontic treatment. These interventions are extensive and irreversible [read the full story…]

Share this post:

Share on FacebookTweet this on TwitterShare on LinkedInShare on Google+Share via email

Drooling is a common problem for children with cerebral palsy (CP). Drooling varies in severity and can be distressing for the children, families and caregivers. It can cause chapped or sore skin around the mouth and chin, skin and mouth infections, dehydration, difficulties chewing and a range of other social issues. The main aim of [read the full story…]

Share this post:

Share on FacebookTweet this on TwitterShare on LinkedInShare on Google+Share via email